Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,222,085
+$1,115,600 QoQ
Shares Held
32,674
-0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#1,024
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jacobi Capital Management LLC holds $62,099,576 across 14 Drug Manufacturers - General names. ABBV ranks #4 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,180 | $17,007,918 | |
| 2 | MRK |
Merck & Co., Inc.
|
71,539 | $9,192,761 | |
| 3 | JNJ |
Johnson & Johnson
|
33,028 | $8,388,121 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
32,674 | $8,222,085 | |
| 5 | AMGN |
Amgen Inc
|
12,553 | $4,545,692 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
64,849 | $3,736,599 | |
| 7 | PFE |
Pfizer Inc
|
133,653 | $3,218,364 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
23,324 | $2,946,754 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,222,085 | 32,674 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $7,106,485 | 32,675 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,511,151 | 32,873 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,767,009 | 33,545 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $6,249,268 | 33,667 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $6,949,987 | 33,171 | Shares | Sole | 2025-05-27 | |
| 2024-12-31 | $5,858,591 | 32,969 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $6,564,037 | 33,239 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,585,377 | 32,564 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,905,503 | 32,430 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $4,922,002 | 31,761 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,665,130 | 31,297 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,226,210 | 31,368 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,213,311 | 32,712 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $5,237,941 | 32,411 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,396,585 | 32,759 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $5,066,685 | 33,081 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,370,704 | 33,130 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,547,950 | 33,589 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,461,116 | 32,086 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,354,982 | 29,785 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,094,659 | 28,596 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,009,414 | 28,086 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $2,468,811 | 28,186 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $2,960,912 | 30,158 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $2,032,901 | 26,682 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||